Upload
eve-purdy
View
2.651
Download
1
Tags:
Embed Size (px)
DESCRIPTION
In an effort to introduce our traditional medical school journal club to the world of twitter-based journal clubs I did traditional review of the 2013 NEJM article on transfusion strategies in acute GI bleeds (http://www.nejm.org/doi/full/10.1056/NEJMoa1211801) with embedded quotes from the recent #twitjc discussion of the same paper. Villanueva, C., Colomo, A., Bosch, A., Concepción, M., Hernandez-Gea, V., Aracil, C., ... & Guarner, C. (2013). Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med, 368, 11-21.
Citation preview
TRANSFUSION STRATEGIES FOR ACUTE UPPER GASTROINTESTINAL BLEEDING
JOURNAL CLUB REVIEW BY EVE PURDY
VILLANUEVA, C., COLOMO, A., BOSCH, A., CONCEPCIÓN, M., HERNANDEZ-GEA, V., ARACIL, C., ... & GUARNER, C. (2013). TRANSFUSION STRATEGIES FOR ACUTE UPPER GASTROINTESTINAL BLEEDING. N ENGL J MED , 368, 11-21.
BACKGROUND• Acute UGI is a common emergency condition with high
morbidity and mortality
• 10% from all causes of bleeding• >50% from bleeding varices (associated with cirrhosis)
• Transfusion helpful in exsanguination but effect less clear in less severe bleeds
• Restrictive vs Liberal
• Few studies in GI bleeding• Rebound hypertension specific factor in bleeding varices• Reduce use of blood products
PURPOSE
To determine whether a restrictive threshold for red-cell transfusion in patients with AGI bleeding more safe and more effective than a liberal transfusion strategy.
In patients > 18 with hematemesis or melena presenting to the ED does treatment according to guidelines with a transfusion threshold < 7g (target range 7-9g) or >9g (target 9-11g) reduce death within 45 days.
PICOT QUESTION
STUDY DESIGN
Inclusions: hematemesis, melena or both
Exclusions: massive bleeding, ACS, vasculopathy, stroke, TIA, transfusion within 90 days, trauma/surgery, lower GI bleeding, a previous decision on the part of the attending physician that the patient should avoid specific medical therapy, Rockall score of 0 and HgB > 12
THOUGHTS?
IMPROVEMENTS TO STUDY DESIGN?
DID INTERVENTION AND CONTROL START WITH THE SAME PROGNOSIS?
• Group allocation: computer generated random numbers with sealed, consecutively numbered, opaque envelopes
• Concealed and randomized• Stratified by presence or absence of cirrhosis (clinical,
biochemical and U/S findings)
PROGNOSTIC BALANCE MAINTAINED? • No blinding BUT:
• Transfusion guidelines applied throughout hospital stay• ALL patients underwent endoscopy in < 6hrs• Appropriate treatment (PUD vs variceal)• No differential cointerventions it would seem• Clinical ability to transfuse if clinical signs of anemia…
unclear
OUTCOMES• Primary: rate of death from any cause within the first 45 days
• Secondary:
• rate of further bleeding: hematemesis or fresh melena with hemodynamic instability or fall of HgB > 2g
• rate of in-hospital complications: untoward events that necessitated active therapy or prolonged hospitalization
THOUGHTS?
GROUPS BALANCED AT END OF STUDY? • 32 withdrew or were withdrawn by study investigators
(equal in both groups)
• Analyzed using intention-to-treat analysis for remaining
RESULTS-HEMOGLOBIN AND TRANSFUSION
Restrictive Liberal
Lower hemoglobin in the 1st 24 hours
Higher hemoglobin the first 24 hors
Lower hemoglobin at discharge
Higher hemoglobin at discharge
51% not transfused 14% not transfused
1.5 units/ transfusion 3.7 units / transfusion
9% protocol violation 3% protocol violation
Hemoglobin 11.6 at day 45 Hemoglobin 11.7 at day 45
RESULTS-FURTHER BLEEDING AND COMPLICATIONS
Restrictive Liberal
10% further bleeding 16% further bleeding
Shorter hospital stay (9.6) Longer hospital stay (11.5)
40% adverse events 48% adverse events
RESULTS- MORTALITYRestrictive Liberal
5% at 45 days 9% at 45 days
Virtually unchanged after adjustment for baseline risk factors (HR= 0.55 [0.33-0.92])
Significantly improves outcomes in patients with class A and B cirrhosis but unchanged in class C cirrhosis
HOW CAN I APPLY THE RESULTS?
BUT!
TAKE HOME MESSAGES• Well designed study with convincing results that restrictive
transfusion studies provide better outcomes then liberal transfusion studies in UGI bleeds
• Better control of further bleeding, rescue therapy and adverse events
• Plausible mechanisms in discussion: transfusion counteracts splanchnic vasoconstrictive response in hypovolemia and may impair clot formation
• Drawbacks
• Unblinded- but very objective outcomes• Physicians were able to override transfusion protocol (<10% in
each group)• Cannot be generalized to those with low risk of bleeding or those
with massive bleeding• More studies needed to see if >6hrs to endoscopy affects results
JOIN THE NEXT TWITTER JOURNAL CLUB DISCUSSION
• #twitjc – meets every other Sunday at 8pm
• Review of articles at: http://www.twitjc.com/2013/01/week-24-to-transfuse-or-nor-to-transfuse-in-upper-gi-bleeds/
• #JC_StE
• #PHTwitJC – public health journal club
• http://phtwitjc.wordpress.com• #microtwjc – microbiology journal club
• http://microtwjc.wordpress.com/about/• AND MANY MORE